HOW MUCH DOES BONE MINERAL DENSITY INCREASE AFTER SHORT-TERM TERIPARATIDE TREATMENT (≤ 12 MONTHS) IN PATIENTS WITH SEVERE OSTEOPOROSIS?

被引：0
|
作者：
Jung, M. H. [1 ]
Ji, Y. I. [2 ]
机构：
[1] Kyunghee Univ Hosp, Seoul, South Korea
[2] Haeundae Paik Hosp, Busan, South Korea
来源：
OSTEOPOROSIS INTERNATIONAL | 2020年 / 31卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P115
引用
收藏
页码：S140 / S140
页数：1
相关论文
共 50 条
  • [11] Short-term bone marker responses to teriparatide and strontium ranelate in patients with osteoporosis previously treated with bisphosphonates
    de Sousa, Isabel Oliveira
    Diniz, Erik Trovao
    Marques, Thyciara Fontenele
    Griz, Luiz
    Pereira Coutinho, Mario de Almeida
    Bandeira, Francisco
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (02) : 244 - 249
  • [12] Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis
    Olsson, A.
    Oturai, D. B.
    Sorensen, P. S.
    Oturai, P. S.
    Oturai, A. B.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (12) : 1557 - 1565
  • [13] The Short-Term Effects of Strontium Ranelate on Pain and Bone Mineral Density in Postmenopausal Women with Osteoporosis
    Koyuncu, Halil
    Erden, Meryem Gul
    Esen, Selma
    TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, 2012, 18 (02): : 53 - 57
  • [14] Low bone mineral density can occur in children after short-term systemic glucocorticoid treatment
    Ahn, Moon Bae
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2022, 65 (06) : 300 - 301
  • [15] EFFECTS OF 12 MONTHS TREATMENT WITH TERIPARATIDE ON VOLUMETRIC BONE MINERAL DENSITY AND STRUCTURAL PARAMETERS AT THE FEMORAL NECK ASSESSED BY QUANTITATIVE COMPUTERIZED TOMOGRAPHY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Bogado, C.
    Brown, K.
    Keaveny, T.
    Dempster, D.
    Zanchetta, J.
    Thomson, D.
    Masiukiewicz, U.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 375 - 376
  • [16] Factors related to the response rate of bone mineral density (BMD) to osteoanabolic therapy (teriparatide/PTH) in patients with severe osteoporosis
    Gifre, Laia
    Monegal, Ana
    Filella, Xavier
    Muxi, Africa
    Guanabens, Nuria
    Peris, Pilar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S321 - S321
  • [17] BONE MINERAL DENSITY AND BONE TURNOVER MARKERS AFTER ONE-YEAR TERIPARATIDE TREATMENT IN KOREAN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Oh, H.
    Choi, W.
    Choi, H.
    Kim, J.
    Lim, S.
    Joo, I.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 183 - 184
  • [18] Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
    A. Blumsohn
    F. Marin
    T. Nickelsen
    K. Brixen
    G. Sigurdsson
    J. González de la Vera
    S. Boonen
    S. Liu-Léage
    C. Barker
    R. Eastell
    Osteoporosis International, 2011, 22 : 1935 - 1946
  • [19] Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
    Blumsohn, A.
    Marin, F.
    Nickelsen, T.
    Brixen, K.
    Sigurdsson, G.
    Gonzalez de la Vera, J.
    Boonen, S.
    Liu-Leage, S.
    Barker, C.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (06) : 1935 - 1946
  • [20] The Effects of Teriparatide Treatment on Back Pain, Quality of Life, Depression and Biochemistry Parameters in Patients with Severe Postmenopausal Osteoporosis: Short-Term Results
    Akyol, Yesim
    Atmaca, Aysegul
    Durmus, Dilek
    Ulus, Yasemin
    Tander, Berna
    Alayli, Gamze
    TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 2011, 57 (03): : 134 - 138
12345